Author: DFNS


DoD Biological Select Agents and Toxins Database

The U.S. Army has announced intentions to negotiate a sole source contract with Battelle Memorial Institute for the Biological Select Agents and Toxins (BSAT) Database for Department of Defense facilities. The BSAT database will...


5M Funds Research to Develop Drugs for Respiratory Diseases

A Washington University in St. Louis drug discovery program has recently received three grants totaling more than $5 million from the National Institutes of Health (NIH) to develop new therapeutics for respiratory diseases. The...


Russia creates new defence company in Crimea

Russia has launched a new defence company in the Crimea as part of an investment in the region’s defence industry, Crimean Industrial Policy Minister Andrey Skrinnik announced on 28 April. Tactical Missiles Corporation subsidiary...


Education as a Tool for Advancing the NPT

Join us May 4 at the Bah’a’i UN Center to explore ways to amplify disarmament and nonproliferation education efforts. The post Education as a Tool for Advancing the NPT appeared first on James Martin...


Sixty Percent of Americans Not Practicing for Disaster

A recent Federal Emergency Management Agency (FEMA) survey found that nearly 60 percent of American adults have not practiced what to do in a disaster by participating in a disaster drill or preparedness exercise...


WMDFZ in the Middle East: What Now?

CNS will host a panel event during the NPT Review Conference to explore ways toward a Middle East zone free of weapons of mass destruction. The post WMDFZ in the Middle East: What Now?...


IOM to Become National Academy of Medicine

The National Academy of Sciences this week voted to change the name of the Institute of Medicine (IOM) to the National Academy of Medicine. The newly named National Academy of Medicine will continue to...


CDC: 2014-2015 Flu Season Drawing to a Close

Flu activity continues to decline, according to the most recent Centers for Disease Control and Prevention (CDC) FluView report, which shows that influenza-like-illness in the United States has fallen below baseline for the second...


Nuclear Power is Russia’s New Weapon of Choice

NEWSWEEK – Russia is using cut-price nuclear energy deals as leverage to influence EU states and shore up long-term alliances in the Middle and Far East, according to energy analysts. Continue reading. …read more...


The Science behind the Iranian Nuclear Deal

If a final Iran nuclear deal adheres to key parameters for Iran’s uranium and plutonium capability, it could herald a new era of international cooperation. The post The Science behind the Iranian Nuclear Deal...


Berkley Nucleonics launch RD-150-G

Berkeley Nucleonics will be releasing the Model RD-150-G at the Annual HPS (Health Physics Society) Conference in Baltimore in July …read more From:: CBRNe World (CBRN)


NIST Develops ‘Fingerprinting’ Method for Antibody Therapies

National Institute of Standards and Technology (NIST) researchers at the Institute for Bioscience and Biotechnology Research (IBBR) have demonstrated the most precise method yet to measure the structural configuration of monoclonal antibodies (mAbs), an...


Emergent BioSolutions Resumes BioThrax Manufacturing

GLOBAL BIODEFENSE – Emergent BioSolutions Inc. last week announced that it has resumed full manufacturing operations of its anthrax vaccine, BioThrax (Anthrax Vaccine Adsorbed), after completing its internal manufacturing investigation. Continue reading. …read more...

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.